Recruiting
Phase 1
Phase 2

Transtympanic Ringer's Lactate for the Prevention of Cisplatin Ototoxicity

Sponsor:

McGill University Health Centre/Research Institute of the McGill University Health Centre

Code:

NCT01108601

Conditions

Hearing Loss

Eligibility Criteria

Sex: All

Age: 15+

Healthy Volunteers: Not accepted

Interventions

Ringer's Lactate (0.03% Ciprofloxacin)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information